| 21791641 |
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors
Sasaki, T,
Koivunen, J,
Ogino, A,
Yanagita, M,
Nikiforow, S,
Zheng, W,
Lathan, C,
Marcoux, JP,
Du, J,
Okuda, K,
Capelletti, M,
Shimamura, T,
Ercan, D,
Stumpfova, M,
Xiao, Y,
Weremowicz, S,
Butaney, M,
Heon, S,
Wilner, K,
Christensen, JG,
Eck, MJ,
Wong, KK,
Lindeman, N,
Gray, NS,
Rodig, SJ,
Jänne, PA
|
Cancer Res. |
2011 |
